Deals
MedMen’s $1.65 Billion Listing Shows Cannabis Is Moving North
- Canadian Securities Exchange a new home for U.S. pot companies
- Expert says firms to ‘hibernate’ there until U.S. rules shift
This article is for subscribers only.
Cannabis company MedMen Enterprises’s deal to go public in Canada with a $1.65 billion valuation is the latest signal the U.S.’s northern neighbor is poised to capture more marijuana investment.
The reverse takeover -- in which a private company goes public via the acquisition of a listed one -- is among the largest deals for marijuana in Canada. With the plant’s legal status still questionable in the U.S., the transaction illustrates the corporate-cannabis industry’s migration north to raise cash from investors eager to latch on to a fast-growing market.